Research Options:
Week of Expected Pricing Pending
Company Name PIERIS PHARMACEUTICALS, INC.
Proposed Ticker N/A
CUSIP 720795103
Business Description A clinical-stage biopharmaceutical company dedicated to the discovery and development of our Anticalin® class of biotherapeutics for patients with diseases in which we believe there is high unmet medical need.
Lead Underwriter JMP Securities LLC, Oppenheimer & Co. Inc.
Co-Managers Roth Capital Partners, Inc, Trout Capital LLC
Initial Shares 96,15,385
Revised Initial Shares N/A
Initial Price $3.12-$3.12
Revised Price N/A
Final Price N/A
Final Ticker N/A

 

 
   
  © 2024 ICE Data Services. All rights reserved.